Terpenes & terpenoids as platform molecules
Fermentation-derived terpenes and terpenoids — farnesene, limonene, valencene, squalane — replacing petrochemical and plant-extracted equivalents in cosmetics, flavors, fragrances and fuel additives as microbial mevalonate-pathway engineering scales.
1 · What it gives
Terpenes and terpenoids — isoprenoid molecules built from five-carbon isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) units — are shifting from plant extraction and petrochemical synthesis to precision fermentation as a platform-chemical category spanning cosmetics, flavors and fragrances, pharmaceuticals and fuel additives. Amyris pioneered the shift at scale: its Biofene fermentation platform produces trans-beta-farnesene from sugarcane-derived sucrose in engineered Saccharomyces cerevisiae, which is then hydrogenated and dimerized into Neossance Squalane — a 100% USDA-certified biobased, Ecocert-approved cosmetic emollient that has captured an estimated 40% of the global high-purity squalane market as of late 2025, produced across four independent fermentation lines at its Barra Bonita facility in Brazil. Manus Bio holds patented enzyme technology (engineered cytochrome P450 and SrKO oxidase variants) for converting sesquiterpenes such as valencene into oxygenated derivatives like nootkatone. In Europe, Evolva and Isobionics (acquired by BASF) both commercialize fermentation-derived valencene at food-grade purity — Isobionics under its Valencene Pure brand, with regulatory acceptance in Japan since 2020, and Evolva at up to 94% purity meeting EU flavor-ingredient rules — while Givaudan continues to launch new fragrance-precursor molecules (Scentaurus PolyDoux, February 2026) alongside its long-standing terpene-derived ingredient lines. China remains, by comparison, primarily an exporter of naturally extracted terpene feedstocks (citrus-processing d-limonene, turpentine derivatives) rather than a confirmed precision-fermentation terpene platform at US/EU scale.
The key directions of terpenes and terpenoids as platform molecules are:
- Mevalonate (MVA) pathway engineering: re-engineering yeast’s native isoprenoid pathway — most notably a truncated, membrane-anchor-free HMG-CoA reductase (tHMGR) plus extra copies of the acetyl-CoA and FPP-synthase genes — to maximize flux toward a target terpene.
- Terpene synthase and oxidase engineering: installing the specific synthase (limonene synthase, farnesene synthase) or oxidase (SrKO-class valencene oxidase) that converts a universal prenyl-pyrophosphate precursor into the target monoterpene, sesquiterpene or oxygenated derivative.
- In-situ product sequestration (ISPS): continuously extracting the terpene into a biocompatible organic phase during fermentation, since terpenes are membrane-toxic to the host cell above roughly 1-2 g/L in the aqueous phase.
- Catalytic downstream conversion: hydrogenating or dimerizing a fermented terpene precursor (e.g., farnesene to squalane) to reach the final commercial molecule.
Sectoral value chain#
[Sugar / lipid feedstock] ──> [Fermentation (MVA/MEP pathway)] ──> [In-situ extraction & separation] ──> [Catalytic refinement]
│
(Distillation / hydrogenation)
│
▼
[B2B release: cosmetics, F&F, fuel] <─── [QA/QC & compliance (REACH, ASTM D6866)] <─── [Purification]
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| 1. Feedstock | Sourcing fermentable sugars (sucrose, glucose) or lipid precursors for the host organism. | In: Sugarcane sucrose, cornstarch glucose. Out: Fermentation feedstock. |
| 2. Fermentation (MVA/MEP pathway) | Culturing engineered yeast or bacteria carrying an optimized isoprenoid pathway and a target terpene synthase. | In: Engineered strain, feedstock, bioreactor. Out: Terpene precursor secreted into the broth. |
| 3. In-situ extraction and phase separation | Continuously partitioning the toxic terpene into an organic solvent phase during fermentation, then separating phases. | In: Biocompatible solvent, centrifugal separators. Out: Crude terpene oil phase. |
| 4. Purification | Vacuum distillation or gas stripping to remove fatty-acid and metabolite byproducts. | In: Crude terpene oil. Out: High-purity terpene monomer. |
| 5. Catalytic refinement | Hydrogenating or dimerizing the purified terpene into the final target molecule where required (e.g. farnesene to squalane). | In: Purified terpene, hydrogen, catalyst. Out: Finished specialty molecule. |
| 6. QA/QC and compliance release | Verifying purity by GC-MS, confirming biogenic carbon content (ASTM D6866) and clearing REACH/food-flavor registration. | In: GC-MS analysis, regulatory dossiers. Out: Certified, B2B-ready product. |
Cross-cutting technologies of the sector:
- Truncated HMG-CoA reductase (tHMGR) pathway engineering: removing the membrane-anchor domain of the rate-limiting mevalonate-pathway enzyme so it stays soluble and active at high copy number, the standard yeast engineering move behind Amyris’s Biofene platform.
- Terpene synthase / oxidase engineering: installing a specific synthase (limonene synthase converting GPP to limonene) or an engineered P450/SrKO-class oxidase (converting valencene to nootkatone) to reach the exact target molecule.
- In-situ product sequestration: an organic solvent overlay added during fermentation that continuously removes the terpene from the toxic aqueous phase, the standard fix for terpenes’ membrane toxicity above roughly 1-2 g/L.
2 · What it replaces 6 · matched by industry
| D1E– | Biosurfactants (rhamnolipids, sophorolipids) instead of petrochemical surfactants in cleaning and industrial formulation Replaces: Petrochemical surfactants in cleaners and formulations - linear alkylbenzene sulfonate (LAS), alcohol ethoxylates (AEO), alkylphenol … | CHEM |
| D1E– | Biosurfactant and APG cleansing — sophorolipids, rhamnolipids, alkyl polyglucosides — instead of petrochemical SLES/SLS Replaces: Petrochemical anionic surfactants (SLES/SLS) and their ethoxylated feedstock chain (1,4-dioxane contamination risk at trace levels, … | COSM |
| D1E– | Bio-based and safer solvents — Cyrene (dihydrolevoglucosenone from cellulose), 2-methyltetrahydrofuran (2-MeTHF from furfural/levulinic acid), ethyl lactate, bio-ethanol, γ-valerolactone, limonene — instead of NMP, DMF, DMAc, dichloromethane and other hazardous solvents Replaces: N-methyl-2-pyrrolidone (NMP), N,N-dimethylformamide (DMF), dimethylacetamide (DMAc), dichloromethane (DCM), chloroform, toluene/xylene in … | CHEM |
| D3E2 | Biodegradable scrub particles and exfoliants instead of polyethylene microbeads Replaces: Polyethylene (and PP/PET/PMMA) microbeads in rinse-off cosmetics: face/body scrubs, toothpastes, shower gels; glitter (polyester/alu … | COSM |
| D1E– | Fermentation cosmetic ingredients instead of shark-liver squalene, rooster-comb hyaluronic acid and animal collagen Replaces: Shark-liver oil squalene (deep-sea shark fisheries); hyaluronic acid from rooster combs; bovine/porcine collagen extracts (and their … | COSM |
| D2E2 | Biodegradable, bio-based lubricants and hydraulic fluids (vegetable-oil and synthetic esters) — instead of mineral-oil lubricants in forestry, agriculture, marine, rail and water-adjacent machinery Replaces: Mineral-oil hydraulic fluids, chainsaw bar oils, gear and stern-tube oils, greases (and total-loss lubricants lost directly to the … | CHEM |
3 · How to implement 6 steps
- 1Aerobic fed-batch yeast fermentationFermentation & cultivationEngineered S. cerevisiae carrying a truncated HMG-CoA reductase and an overexpressed farnesene synthase is grown in fed-batch mode on sugarcane-derived sucrose, secreting trans-beta-farnesene as fermentation proceeds.Who can do this step matched automaticallyOnDemandBio South Koreaindustrial scale“OnDemandBio is a South Korean deep-tech startup specializing in precision fermentation and synthetic biology to produce high-value biomaterials for the food, healthcare, and …”PhaBuilder 微构工场 China✓ GMP 30,000 tons/year industrial scale“[公司介绍 - 微构工场 — Microconstruct Farm (微构工场) focuses on biomanufacturing of PHA (polyhydroxyalkanoates), a green biopolymer.”“Aum Enzymes is a metabolic engineering firm specializing in generally regarded safe microbial origin Industrial, Food, Feed, Neutraceutical, cosmetic, plant origin [botonical] …”Bota Bio 恩和生物 China✓ ISO 9001 600 tons pilot scale“Bota Biosciences is a global leader in Physical AI-driven biomanufacturing, dedicated to making biotechnology a reliable and scalable engine of productivity.”Zhejiang NHU Company China✓ GMP industrial scale“(NHU; SZSE: 002001) is a functional chemicals company producing nutrition ingredients (vitamins, amino acids, carotenoids), aroma chemicals, polymer/new materials (including PPS), …”CABIO 嘉必优 (SSE 688089) China✓ ISO 9001 600 tons“生产与产业化:与合作伙伴(如中科院、美国嘉吉等)共同推进发酵法多不饱和脂肪酸的产业化、建立微生物油脂工厂、实现国内外市场布局。”
- 2In-situ farnesene extraction (ISPS)ExtractionField application & servicesA biocompatible organic solvent phase is continuously introduced into the fermenter, partitioning the secreted farnesene out of the toxic aqueous phase and protecting the yeast from membrane damage as titers rise.Who can do this step matched automatically“Aum Enzymes is a metabolic engineering firm specializing in generally regarded safe microbial origin Industrial, Food, Feed, Neutraceutical, cosmetic, plant origin [botonical] …”India Glycols (NSE) India✓ GMP ✓ ISO 9001 7,500 MT/ industrial scale“ Novel technologies, including super critical technology for nutraceuticals where carbon dioxide is used as a green solvent during extraction processes.”String Bio Indiaindustrial scale“Latest major 2025–2026 signals of ongoing activity: a 2025 field trial completion for CleanRise in Vietnam is referenced (Agro Spectrum India, 2025-12-02), plus 2026 …”Paul Mueller Company United States✓ GMP“Preventing those disruptions requires more than reactive repairs; it demands proactive maintenance, routine inspections, and experienced service partners. Together, Paul Mueller …”
- 3Phase separation and crude oil recoveryPurification & downstreamThe fermentation broth is processed through centrifugal separators that split it into a yeast-biomass fraction, an aqueous fraction and the crude farnesene oil phase, which is then washed to remove residual cell-culture solids.Who can do this step matched automatically✓ GMP ✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”✓ GMP industrial scale“testing, including mass spectrometry and analytical high performance liquid chromatography”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”Tsukishima Kikai Japan✓ ISO 9001“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
- 4Vacuum distillation to high-purity farneseneThe crude oil undergoes vacuum distillation to strip residual fatty acids and yeast metabolites, yielding trans-beta-farnesene at the high purity required for downstream catalytic conversion.
- 5Catalytic hydrogenation to squalaneThe purified farnesene is hydrogenated and dimerized over a metal catalyst under pressurized hydrogen, saturating its double bonds to yield stable, fully saturated squalane (C30H62).
- 6Filtration, QA/QC and B2B releaseTesting & analyticsPurification & downstreamThe product is filtered to remove residual catalyst, analyzed by GC-MS to confirm purity and biogenic carbon content, and packaged for shipment to cosmetic and pharmaceutical formulators under long-term B2B supply agreements.Who can do this step matched automatically✓ GMP ✓ ISO 9001 500 m3“Development of robust, scalable fermentation and downstream processing (production and recovery/yield optimization).”BRAIN Biotech Germany✓ ISO 9001 industrial scale“As a contract research organization (CRO), we provide smart, rapid, and effective solutions using cutting-edge technologies to drive customer success.”HLB Genex (ex-GenoFocus) South Koreaindustrial scale“With fungal and bacterial secretion systems, we custom produce the evolved enzyme products in large-scale fermentation and downstream processes.”✓ GMP industrial scale“ProBio: A global CRDMO (contract research, development, and manufacturing organization) providing end-to-end solutions for biologics and cell and gene therapy (CGT).”Tsukishima Kikai Japan✓ ISO 9001“Crystallization and refining: In-house developed DP Crystallizer and Oslo Crystallizer for tailored crystallization and refining processes; integrated purification units combining …”
4 · Who delivers
Matched suppliers (matched automatically)
| Fermelanta | Japan | Producer | active |
| Tsingke Biotechnology | China | Producer | active |
| HLB Genex (ex-GenoFocus) | South Korea | Producer | active |
| Aum Enzymes / Infinita Biotech | India | Producer | active |
| Evogene (NASDAQ: EVGN) | Israel | Not classified | active |
In the services and supply catalogue 1 · paid service
Contract manufacturing (CMO/CDMO/toll)
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Amyris | 🇺🇸 USA | Biofene farnesene, Neossance Squalane | MVA pathway engineering, tHMGR, ~40% global squalane share | commercial |
| Manus Bio | 🇺🇸 USA | Oxygenated terpenoids (nootkatone/nootkatol) | Engineered P450/SrKO oxidase cascades | operating |
| Evolva | 🇨🇭 Switzerland | Fermentation-derived valencene (up to 94% purity) | EU flavor-regulation-compliant fermentation | operating |
| Isobionics (BASF) | 🇳🇱 Netherlands | Valencene Pure | Food-grade fermentation, Japan-approved since 2020 | operating |
| Givaudan | 🇨🇭 Switzerland | Scentaurus PolyDoux, terpene-derived F&F ingredients | Fragrance-precursor molecule design | commercial |
5 · Rules & route to market
state registration ~10-15 working days after expert assessment; new substances need notification
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The United States hosts the platform’s most scaled commercial producer (Amyris) alongside enzyme-engineering specialists building the next generation of oxygenated terpenoids.
Amyris’s squalane-scale fermentation, Manus Bio’s oxidase-engineered nootkatone, post-2024 B2B pivot#
- Amyris: its Biofene fermentation platform converts Brazilian sugarcane sucrose into trans-beta-farnesene via engineered S. cerevisiae, then hydrogenates and dimerizes it into Neossance Squalane, holding an estimated 40% share of the global high-purity squalane market as of late 2025 across four fermentation lines at its Barra Bonita, Brazil facility; the company restructured out of Chapter 11 in 2024 to focus on B2B ingredient supply for partners including Givaudan and DSM-Firmenich.
- Manus Bio: holds patented technology (filed and granted 2024-2026) for producing oxygenated sesquiterpenes such as nootkatone and nootkatol from valencene using engineered cytochrome P450 and SrKO-class oxidase enzymes expressed in bacterial or yeast host cells.
- Regulatory context: the FDA’s GRAS (Generally Recognized as Safe) pathway for fermentation-derived flavor and fragrance molecules continues to be the standard route to market for US-produced terpenes in food, cosmetic and fragrance applications.
European Union
Europe hosts two independent commercial valencene-fermentation producers plus a leading fragrance house continuing to launch new terpene-adjacent ingredients.
Isobionics/BASF and Evolva’s food-grade valencene, Givaudan’s 2026 fragrance-precursor launches, EU flavor-regulation compliance#
- Isobionics (BASF): commercializes fermentation-derived valencene under its Valencene Pure brand at food-grade purity, with regulatory acceptance in Japan since 2020 and continued production scale-up under BASF ownership.
- Evolva: produces fermentation-derived valencene at up to 94% purity, meeting EU flavor-ingredient regulation (EU 1334/2008) requirements for use in food and beverage applications.
- Givaudan: launched Scentaurus PolyDoux, the latest addition to its fragrance-precursor palette, in February 2026, and continued to unveil new Active Beauty ingredient innovations at in-cosmetics Global 2026 — part of a long-standing terpene-derived ingredient portfolio (patchoulol, ambroxide-class molecules) alongside partners such as Amyris.
China
China’s terpene sector remains centered on natural extraction and export of feedstocks rather than a confirmed, at-scale precision-fermentation platform comparable to its US/EU peers.
Natural feedstock export base, REACH-oriented compliance for exporters, no independently confirmed fermentation-scale producer#
- Natural feedstock base: China remains a major global source of naturally extracted terpene feedstocks — citrus-processing byproduct d-limonene and pine-derived turpentine fractions — supplying downstream fragrance, solvent and specialty-chemical formulators.
- Export compliance orientation: Chinese exporters of terpene-derived chemicals into the EU market operate under REACH registration and increasingly pursue ISCC PLUS-style sustainability certification to meet buyer requirements.
- Fermentation-platform gap: unlike the US and EU, no China-based precision-fermentation terpene producer could be independently confirmed via a live 2026 source at the scale of Amyris, Evolva or Isobionics — the sector’s build-out here lags its natural-extraction base.
6 · Money: tenders & grants
| Grant | NSF Scholarships in Science, Technology, Engineering, and Mathematics Program U.S. National Science Foundation · United States | Mar 2, 2027 137 days |
| Grant | Pioneering Aerospace Capabilities, Engineering and Research (PACER) Air Force -- Research Lab · United States | May 10, 2043 6050 days |
| Grant | Replacing hazardous substances in biocidal products European Commission · EU | Sep 22, 2027 341 days |
Public R&D projects 1
Publicly funded research projects (US NSF, and EU, UK and other funders via OpenAIRE) whose title names this technology — matched by title, not reviewed; amounts as awarded, in the funder's currency. all funded projects →
| 2026 | SBIR Phase II: Microbial Stem Cell Technology for High-Yield Terpene Biomanufacturing NSF · 2528068 | 1,250,000 USD |
7 · Tech stack & innovations
The terpene-platform stack pairs isoprenoid pathway engineering with downstream extraction and catalytic conversion to reach a specific commercial molecule:
- Mevalonate pathway engineering (tHMGR):
- Truncating HMG-CoA reductase to remove its membrane-anchor domain keeps the rate-limiting mevalonate-pathway enzyme soluble and stable at high expression levels, the core engineering move behind scaled yeast-based terpene platforms such as Amyris’s Biofene.
- Terpene synthase and oxidase engineering:
- Installing a specific terminal enzyme — a synthase converting a universal prenyl-pyrophosphate precursor into a target terpene, or an oxidase (SrKO-class, as used by Manus Bio) converting one terpene into an oxygenated derivative like nootkatone — determines which exact molecule a given engineered strain produces.
- In-situ product sequestration (ISPS):
- Because terpenes are toxic to the host cell’s membrane above roughly 1-2 g/L in the aqueous phase, an organic solvent phase is fed continuously into the fermenter to extract the terpene as it is produced, allowing much higher overall titers than would otherwise be possible.
Sources 5 · 0 independent · 5 producer sites
Producers' own sites 5
- Amyris producer checked 2026-03-13 · link not kept
- Manus bio producer checked 2026-05-14 · link not kept
- Givaudan producer checked 2026-04-11 · link not kept
- Evolva producer checked 2024-08-07 · link not kept
- Isobionics producer checked 2024-08-07 · link not kept